Semler Scientific (SMLR) Misses Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Semler Reports First Quarter 2015 Financial Results
May 1, 2015 8:03 AM EDTPORTLAND, Ore., May 1, 2015 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), an emerging medical risk assessment company that develops, manufactures and markets products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today reported financial results for the first quarter ended March 31, 2015.
"In the first quarter of 2015, Semler reported continued progress with year over year growth of 44% and sequential quarter over quarter revenue growth of 14%," said Doug Murphy-Chutorian, M.D., chief executive officer of Semler. "We expanded installations of our FloChec® product with established large insurance plan customers, made progress... More
